Drugs / ICG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05965817 | Dec 2023 → Mar 2025 | metastasis from malignant tumor of colon | Leiden University Medical Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ICG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05965817 ↗ |
| Modality | Diagnostic / imaging agent | “the use of intra-operative ICG for fluorescent tumour delineation has widely been adopted as standard of care.” NCT05965817 ↗ |